Causeway Sensors are experts at manufacturing on the nanoscale – on the scale of atoms and molecules. At the nanoscale, materials and their interaction with light behave quite differently.
The company have developed a chip with a billion gold nanorods that act as interacting optical antennae. The resonant frequency of these nanostructures is highly sensitive to changes in mass at their surface, making them ideal for biological sensing applications. We have built an accompanying device that sensitively reads biological detection events at the chip surface.
Rapid detection of clinically relevant biomarkers and pathogens from biological samples is central to the diagnosis of disease. Current hospital practice involves taking blood samples from the patient and sending these samples to a central laboratory for processing. The turnaround time from sample to diagnosis can range from several hours to days.
Causeway Sensors are creating a disruptive technology that will offer a paradigm shift in health care diagnostics. Our rapid point-of-care platform will address diagnostic bottlenecks, giving clinicians accurate data in minutes, enabling quick prescription of the correct treatment.
The technology will have its greatest impact in infectious diseases like sepsis, where survival rates drop by 8% every hour it is untreated.